Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
256,606,920
-
Total 13F shares
-
235,422,568
-
Share change
-
+1,715,079
-
Total reported value
-
$68,198,221,131
-
Put/Call ratio
-
84%
-
Price per share
-
$289.54
-
Number of holders
-
1,091
-
Value change
-
+$549,977,421
-
Number of buys
-
520
-
Number of sells
-
471
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q3 2022
As of 30 Sep 2022,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
1,091 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
235,422,568 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, FMR LLC, Capital World Investors, STATE STREET CORP, ALLIANCEBERNSTEIN L.P., WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, and JPMORGAN CHASE & CO.
This page lists
1,105
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.